Aurélien Jacob

1.0k total citations
10 papers, 575 citations indexed

About

Aurélien Jacob is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Aurélien Jacob has authored 10 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Genetics and 4 papers in Oncology. Recurrent topics in Aurélien Jacob's work include Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (7 papers) and CAR-T cell therapy research (4 papers). Aurélien Jacob is often cited by papers focused on Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (7 papers) and CAR-T cell therapy research (4 papers). Aurélien Jacob collaborates with scholars based in Italy, United States and France. Aurélien Jacob's co-authors include Samuele Ferrari, Pietro Genovese, Luigi Naldini, Luisa Albano, Valentina Vavassori, Ivan Merelli, Stefano Beretta, Giulia Schiroli, Chiara Brombin and Maria Carmina Castiello and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Aurélien Jacob

10 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurélien Jacob Italy 8 488 316 168 77 61 10 575
Samuele Ferrari Italy 10 616 1.3× 371 1.2× 218 1.3× 95 1.2× 75 1.2× 20 746
Claudia Firrito Italy 4 393 0.8× 224 0.7× 108 0.6× 70 0.9× 58 1.0× 8 515
Valentina Vavassori Italy 7 366 0.8× 216 0.7× 132 0.8× 59 0.8× 43 0.7× 10 448
Beatriz Campo-Fernández United States 12 516 1.1× 264 0.8× 122 0.7× 61 0.8× 89 1.5× 16 635
Zulema Romero United States 13 532 1.1× 300 0.9× 123 0.7× 52 0.7× 59 1.0× 19 649
Carmencita E. Nicolas United States 2 684 1.4× 314 1.0× 133 0.8× 51 0.7× 75 1.2× 2 776
Giulia Schiroli United States 7 786 1.6× 501 1.6× 252 1.5× 110 1.4× 95 1.6× 14 955
Nikoletta Psatha United States 15 472 1.0× 293 0.9× 115 0.7× 56 0.7× 46 0.8× 32 661
Anastasia Lomova United States 6 299 0.6× 144 0.5× 95 0.6× 40 0.5× 32 0.5× 6 381
Megan D. Hoban United States 9 426 0.9× 222 0.7× 87 0.5× 49 0.6× 41 0.7× 19 569

Countries citing papers authored by Aurélien Jacob

Since Specialization
Citations

This map shows the geographic impact of Aurélien Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Jacob more than expected).

Fields of papers citing papers by Aurélien Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélien Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Jacob. The network helps show where Aurélien Jacob may publish in the future.

Co-authorship network of co-authors of Aurélien Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélien Jacob. A scholar is included among the top collaborators of Aurélien Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélien Jacob. Aurélien Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Asperti, Claudia, Daniele Canarutto, Simona Porcellini, et al.. (2023). Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo. Molecular Therapy — Methods & Clinical Development. 30. 546–557. 3 indexed citations
2.
Canarutto, Daniele, Claudia Asperti, Valentina Vavassori, et al.. (2023). Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4 + T‐cells for the treatment of Hyper IgM1. The EMBO Journal. 42(23). e114188–e114188. 5 indexed citations
3.
Omer, Attya, Luisa Albano, Claire Latroche, et al.. (2022). Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells. Cell. 185(13). 2248–2264.e21. 36 indexed citations
4.
Galibert, Lionel, et al.. (2021). Monobac System–A Single Baculovirus for the Production of rAAV. Microorganisms. 9(9). 1799–1799. 13 indexed citations
5.
Ferrari, Samuele, Stefano Beretta, Aurélien Jacob, et al.. (2021). BAR-Seq clonal tracking of gene-edited cells. Nature Protocols. 16(6). 2991–3025. 9 indexed citations
6.
Ferrari, Samuele, Valentina Vavassori, Daniele Canarutto, et al.. (2021). Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation. SHILAP Revista de lepidopterología. 3. 618378–618378. 30 indexed citations
7.
Ferrari, Samuele, Aurélien Jacob, Stefano Beretta, et al.. (2020). Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking. Nature Biotechnology. 38(11). 1298–1308. 108 indexed citations
8.
Jacob, Aurélien, Mohammed Bouzelha, Luk H. Vandenberghe, et al.. (2020). Homologous Recombination Offers Advantages over Transposition‐Based Systems to Generate Recombinant Baculovirus for Adeno‐Associated Viral Vector Production. Biotechnology Journal. 16(1). 9 indexed citations
9.
Schiroli, Giulia, Anastasia Conti, Samuele Ferrari, et al.. (2019). Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response. Cell stem cell. 24(4). 551–565.e8. 203 indexed citations
10.
Schiroli, Giulia, Samuele Ferrari, Anthony Conway, et al.. (2017). Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Science Translational Medicine. 9(411). 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026